Effects and mechanisms of catechin for adjuvant arthritis in rats

Advances in Therapy

Volumn 24, Issue 3, 2007, Pages 679-690

  Tang, Li Qin ^a   Wei, Wei ^a   Wang, Xiao Yu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant arthritis (AA); cAMP; Catechin; Cytokines; EP 2

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CATECHIN; CYCLIC AMP; FREUND ADJUVANT; INTERLEUKIN 1; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; TRIPTERYGIUM WILFORDII EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INFLAMMATION; MALE; NONHUMAN; PAIN ASSESSMENT; PAW EDEMA; POLYARTHRITIS; RADIOIMMUNOASSAY; RAT; SYNOVIOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CATECHIN; CYCLIC AMP; CYTOKINES; JOINT CAPSULE; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; TEA;

EID: 34548074735     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02848793     Document Type: Article

References (25)

1. Jacobson PB, Morgan SJ, Wilcox DM, et al. A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat. Arthritis Rheum. 1999;42:2060-2073.
2. Gao HY, Wu B, Li W, Chen DH, Wu LJ. Chemical constituents of Chaenomeles sinensis (Thouin) Koehne. Chinese J Nat Med. 2004;2:351-353.
3. Feng WY. Metabolism of green tea catechins: an overview. Curr Drug Metab. 2006;7:755-809.
4. Jin Y, Zhao YQ, Ni CL. Chemical constituents of Acacia catechu (L.f) wild. Chinese Tradit Herb Drugs. 2005;36:790-792.
5. Liu XQ, Li WW, Sheng KX, Liu J, Chen FK. Studies on the chemical constituents of the n-Buoh extract of Polygonum bistorta. J Shenyang Pharmaceut Univ. 2006;23:15-17.
6. Haqqi TM, Anthony DD, Gupta S, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A. 1999;96:4524-4529.
7. Adcocks C, Collin P, Buttle DJ. Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type-II collagen degradation in vitro. J Nutr. 2002; 132:341-346.
8. Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β- induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther. 2004;308:767-773.
9. Wei W, Chen MZ, Xu SY. Pharmacological effects of isoxicam. Chinese Pharmacol Bull. 1986;2:29-34.
10. Chen Q, Wei W. Effects and mechanisms of glucosides of Chaenomeles speciosa on collagen-induced arthritis in rats. Int Immunopharmacol. 2003;3:593-608.
11. Pezet S, Qnteniente B, Jullien J, et al. Differential regulation of NGF receptors in primary sensory neurons by adjuvant-induced arthritis in the rat. Pain. 2001;10:113-125.
12. Dai M, Wei W, Shen YX, Zheng YQ. Glucosides of Chaenomeles speciosa remit rat adjuvant arthritis by inhibiting synoviocyte activities. Acta Pharmacol Sin. 2003;24:1161-1166.
13. Müller-Decker K, Scholz K, Marks F, Fürstenberger G. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinogen. 1995;12:31-41.
14. Roubenoff R, Freeman LM, Smith DE, Abad LW, Dinarello CA, Kehayias JJ. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 1997;40:534-539.
15. Taylor PC. Anti-tumor necrosis factor therapies. Curr Opin Rheumatol. 2004;13:164-169.
16. Dayer JM, Feige U, Edwards CK 3rd, Burger D. Antiinterleukin-1 therapy in rheumatic disease. Curr Opin Rheumatol. 2001;13:170-176.
17. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and IL-1: a potential mechanism for inflammatory angiogenesis. FEBS Letters. 1995;372:83-87.
18. Amano S, Naganuma K, Kawata Y, Kawakami K, Kitano S, Hanazawa S. Prostaglandin E2 stimulates osteoclast formation via endogenous IL-1β expressed through protein kinase A. J Immunol. 1996;156:1931-1936.
19. 2: selective enhancement of collagenase gene expression in human dermal fibroblasts in culture. J Cell Biochem. 1994;54:465-472.
20. Dumont JE, Jauniaux JC, Roger PP. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci. 1989;14:67-71.
21. Yamada T, Terada Y, Homma MK, et al. AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells. Kidney Int. 1995;48:745-752.
22. Prabhakar U, Lipshutz D, O'Leary-Bartus J, et al. Characterization of cyclic AMP-dependent inhibition of LPS-induced TNF-α production by rolipram, a specific phosphodiesterase inhibitor. Int Immunopharmacol. 1994;16:805-816.
23. Katsuyama M, Ikegami R, Karahashi H, Amano F, Sugimoto Y, Ichikawa A. Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. Biochem Biophys Res Commun. 1998;251:727-731.
24. Yoshida T. Involvement of prostaglandin E(2) in interleukin-1alpha- induced parathyroid hormone-related peptide production in synovial fibroblasts of patients with rheumatoid arthritis. J Clin Endocrinol Metab. 2001;86:3272-3278.
25. Morris AJ, Malbon CC. Physiological regulation of G protein-linked signaling. Physiol Rev. 1999;79:1373-1430.